Product
Supplier
Encyclopedia
Inquiry
erlotinib hydrochloride buy - large image1
erlotinib hydrochloride buy - image1

erlotinib hydrochloride

2 Inquiries

Unit Price: Get Latest Price
CAS No.:

183319-69-9

Grade:

Industrial Grade

Content:

99%

Port:

SHANGHAI

Packaging:

25kg/Cardboard Drum

Price valid (until):

2020-08-19

Company Type:
Manufactory
Location:
China
Payment Terms:
TT against copy of documents
Average Lead Time:
7 days
Qualification:
Main Products:

Anti-tumor categories,Cardiovascular,Anti-Diabetes Class,4-(4-bromo-2-fluoroanilino)-6-methoxy-1H-quinazolin-7-one,4-Amino-3-chlorophenol hydrochloride,4-Amino-3-chlorophenol

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    MF:C22H24ClN3O4
    MW:429.9
    EINECS:620-491-0
    Properties
    Melting point:223-225°C
    storage temp. -20°C Freezer
    form Yellow powder.
    pkapKa (25°): 5.42

    The listed products which involve patents, are only for research and development ,and not used for sales.

    Regulated products will be sold in strict accordance with the laws of China and the laws of the buyer's country.

    All products are not for human use ,and all risks associated with the sale to the country that constitutes a patent infringement shall be borne by the buyer.

    ECHEMI Editorial Reference
    Erlotinib hydrochloride inhibits purified EGFR kinase with an IC50 of 2 nM.
    Erlotinib Hydrochloride is the hydrochloride salt of a quinazoline derivative with antineoplastic properties. Competing with adenosine triphosphate, erlotinib reversibly binds to the intracellular catalytic domain of epidermal growth factor receptor (EGFR) tyrosine kinase, thereby reversibly inhibiting EGFR phosphorylation and blocking the signal transduction events and tumorigenic effects associated with EGFR activation.|A quinazoline derivative and ANTINEOPLASTIC AGENT that functions as a PROTEIN KINASE INHIBITOR for EGFR associated tyrosine kinase. It is used in the treatment of NON-SMALL CELL LUNG CANCER.

    Basic Info
    Product Name:

    Erlotinib hydrochloride

    Other Name:

    4-Quinazolinamine,N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-,hydrochloride (1:1);4-Quinazolinamine,N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-,monohydrochloride;CP 358774;OSI 774;Tarceva;6,7-Bis(2-methoxyethoxy)-4-(3-ethynylanilino)quinazoline hydrochloride;[6,7-Bis(2-methoxyethoxy)quinazolin-4-yl]-(3-ethynylphenyl)amine hydrochloride;Erlotinib hydrochloride

    CAS No.:

    183319-69-9

    Molecular Formula:

    C22H23N3O4.ClH

    InChIKeys:

    InChIKey=GTTBEUCJPZQMDZ-UHFFFAOYSA-N

    Molecular Weight:

    429.89700

    Exact Mass:

    429.14600

    UNII:

    DA87705X9K

    NSC Number:

    718781

    DSSTox ID:

    DTXSID10171412

    NCI Thesaurus Code:

    C2693

    ATC Code:

    L01EB02

    HScode:

    2933990090

    Categories:

    Antineoplastic Agents

    Characteristics
    PSA:

    74.73000

    XLogP3:

    4.28010

    Appearance:

    White or off-white powder

    Melting Point:

    219-221 °C @ Solvent: Methanol

    Boiling Point:

    553.6ºC at 760 mmHg

    Flash Point:

    288.6ºC

    Vapor Pressure:

    4.52E-12mmHg at 25°C

    Hazard Identification

    Classification of the substance or mixture

    Acute toxicity - Category 4, Oral

    Carcinogenicity, Category 2

    Reproductive toxicity, Category 2

    Hazardous to the aquatic environment, long-term (Chronic) - Category Chronic 2

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Warning

    Hazard statement(s)

    H302 Harmful if swallowed

    H351 Suspected of causing cancer

    H361 Suspected of damaging fertility or the unborn child

    H411 Toxic to aquatic life with long lasting effects

    Precautionary statement(s)
    Prevention

    P264 Wash ... thoroughly after handling.

    P270 Do not eat, drink or smoke when using this product.

    P203 Obtain, read and follow all safety instructions before use.

    P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...

    P273 Avoid release to the environment.

    Response

    P301+P317 IF SWALLOWED: Get medical help.

    P330 Rinse mouth.

    P318 IF exposed or concerned, get medical advice.

    P391 Collect spillage.

    Storage

    P405 Store locked up.

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    Anti-tumor categories,Cardiovascular,Anti-Diabetes Class,4-(4-bromo-2-fluoroanilino)-6-methoxy-1H-quinazolin-7-one,4-Amino-3-chlorophenol hydrochloride,4-Amino-3-chlorophenol

    Location:

    No.9 Weidi Road-Jiangsu Life Science and Technology Innovation Park, Nanjing, P.R.C

    Payment Terms:

    TT against copy of documents

    Average lead Time:

    7 days

    Total Annual Revenue:

    $2.5 million-$5 million

    Total Employees:

    11-50

    Year of Establishment:

    2008

    Company Certificates
    • Nanjing CHICO Pharmaceutical Co., Ltdbusiness license business license

    Nanjing CHICO Pharmaceutical Co., Ltd is a high-tech enterprise specializing in R&D, production and sales of APIs and pharmaceutical intermediates. We are recognized as National High-Tech Enterprises by Science and Technology Department of Jiangsu Province in 2014.Adhering to the "Consummate service Convincing honor" business strategy, CHICO will provide you the qualified products and first-class service which are based on our strong technical accumulation and outstanding professionalism.

    CHICO was established in July 2008, our sales office and R&D center is located in No.9 Weidi Road -Jiangsu life science and Technology Innovation Park, covering an area of about 1800 square meters. Our GMP factory is located in AnQing--- AnQing CHICO pharmaceutical Co., LTD, with a total area of 20000 square meters. Meanwhile, we also have set our cooperative production base in Huai’an. Now we have a complete ,stable production chain of gram-kilogram-ton so that we can achieve rapid response in the whole R&D-scale up- producing process for new products at the first time.

    We always regard the quality as life, thus we have established our quality department which is directly controlled by GM. Also we have set a perfect quality assurance system and strict quality control standards according to the GMP requirements' and we have already passed the ISO 9001 quality system certification.

    We warmly thank the new and old customers that support and cooperate with us. We sincerely look forward to using "integrity, quality, efficient, professional" service to enhance mutual friendship and create brilliance hand in hand with you!


  • Inquiry History
    2 Inquiries
    Country Product Purchase Quantity Date Posted
    Pakistan

    Erlotinib Hydrochloride

    1 KG Jun 23, 2025
    Pakistan

    ERLOTINIB HCL

    3.00 KG Dec 31, 2024
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.